Immunofluorescence and co-immunoprecipitation assays were performed to determine whether the increased MDM2 expression induced by elevated LNC CYBG3 can inhibit the combination of MTBP and ACTN4 in NSCLC cells. Here, MDM2 is linked to non-small cell lung carcinoma.